Switzerland: Haya Therapeutics, a company developing medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), announced the close of its Sfr18m (US$20m) seed round. The financing was led by…
Switzerland: Haya Therapeutics, a company developing medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), announced the close of its Sfr18m (US$20m) seed round. The financing was led by…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


